Sg Americas Securities, LLC Athira Pharma, Inc. Transaction History

Sg Americas Securities, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 28, 2023	BUY	$2.26 - $4.22 $17,142 - $32,008	7,585 Added 63.6%	19,512 $49,000
Q4 2022 Feb 02, 2023	SELL	$2.76 - $3.71 $5,048 - $6,785	-1,829 Reduced 13.3%	11,927 $38,000
Q3 2022 Oct 31, 2022	BUY	$2.93 - $3.96 $3,668 - $4,957	1,252 Added 10.01%	13,756 $41,000
Q2 2022 Jul 29, 2022	BUY	$2.74 - $13.43 $34,260 - $167,928	12,504 New	12,504 $38,000
Q1 2022 Apr 29, 2022	SELL	$8.96 - $13.51 $78,337 - $118,117	-8,743 Closed	0 $0
Q4 2021 Feb 07, 2022	SELL	$9.17 - $16.39 $97,266 - $173,848	-10,607 Reduced 54.82%	8,743 $114,000
Q3 2021 Nov 01, 2021	BUY	$9.15 - $11.09 $177,052 - $214,591	19,350 New	19,350 $182,000

16.9M

112K

68K

Ticker ATHA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,817,700
Market Cap $21.9M
Description
Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg Americas Securities, LLC with notifications on news.